In combination with negative selection for leukocyte specific markers, various markers are used to detect melanoma cells in peripheral blood, including CD146, melanoma-associated chondroitin sulfate proteoglycan, ATP-binding cassette subfamily B member 5, CD271, and receptor activator of NF-κB. This evidence concerns the gene TNFRSF11A and melanoma.